• Post Market Surveillance

    By strengthening post-market surveillance we establish an effective monitoring system.

  • Industry Regulation

    We ensure that all drugs and related products comply with and adhere to statutory requirements

  • Compliance with Standards

    Drugs and other products are regularly tested for compliance. This photograph shows a condom testing machine.

  • Testing and Research

    Scientists in the microbiology lab testing samples

  • Report Adverse Drug Reactions

    Adverse Drug Reactions

    Always report adverse drug reactions. Click here to report

Quality Assurance

Functions of Department

· Provision of oversight and direction of systems and processes

· Harmonization of quality documents of Pharmacy Board of Sierra Leone for implementation and accreditation as per the international organization for standardization (this includes but not limited to ISO9001 for all departments and ISO17025 for the laboratory)

· Ensure continual improvement of all processes to meet national and international best practices and customer satisfaction through the use of robust measures of review and assessment. 

 

Welcome to Our Website

The Pharmacy Board of Sierra Leone is the medicines regulatory agency in the country and was set up by an Act of Parliament in 1988 with the mission of ensuring that appropriate and workable regulatory guidelines are implemented in order to achieve the highest practicable standards of the practice of pharmacy by professionals and of safety, efficacy and quality of all drugs, medical devices, cosmetics and nutritional agents (collectively termed ‘products) locally manufactured, imported, exported, distributed, sold or used to ensure the protection of the public health as envisaged by the Pharmacy and Drugs Act...Read More

Public Notice: Drug Alert

Information making rounds on social media about a certain drug called “Menthodex” (pictured below) with an incorrect manufacturing date has been brought to the attention of the pharmacy board. From our investigations, our findings indicate that regulators intercepted the drug in Nigeria and due to our bilateral ties with National Agency for Food and Drug Administration and Control (NAFDAC) Nigeria the Board was notified to be extra vigilant for the product in our market. The board has intensified its post-market surveillance and we will continue to keep the general public updated.

The general public is hereby advised to carefully check the manufacturing details of drugs they purchase and should be rest assured that products registered by Pharmacy Board of Sierra Leone are of good quality, efficacious and safe.

            February, 2019

 

 

29

Jan

Press Release

Important announcement concerning a brand of amoxycillin capsules that allegedly caused two deaths, according to an audio clip in circulation. The Board is unaware of and has never registered such a brand of amoxycillin. Read More

31

Jan

Drug Alert: Chloroquine

With immediate effect, Chloroquine phosphate injection manufactured by Syncom Formulations Ltd, India, is to be withdrawn from circulation and quarantined. Read More